James C Momtazee - Net Worth and Insider Trading

James C Momtazee Net Worth

The estimated net worth of James C Momtazee is at least $2 Million dollars as of 2024-05-04. James C Momtazee is the Director of BridgeBio Pharma Inc and owns about 88,491 shares of BridgeBio Pharma Inc (BBIO) stock worth over $2 Million. Details can be seen in James C Momtazee's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James C Momtazee has not made any transactions after 2021-12-29 and currently still holds the listed stock(s).

Transaction Summary of James C Momtazee

To

James C Momtazee Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James C Momtazee owns 9 companies in total, including Montes Archimedes Acquisition Corp (MAACU) , BridgeBio Pharma Inc (BBIO) , and PRA Health Sciences Inc (PRAH) among others .

Click here to see the complete history of James C Momtazee’s form 4 insider trades.

Insider Ownership Summary of James C Momtazee

Ticker Comapny Transaction Date Type of Owner
MAACU Montes Archimedes Acquisition Corp 2021-09-30 director & 10 percent owner & Chief Executive Officer
BBIO BridgeBio Pharma Inc 2021-12-29 director
PRAH PRA Health Sciences Inc 2020-05-18 director
2018-02-28 director
2007-05-31 director
2008-04-29 director & other: See Remarks
2007-05-07 director
2005-10-12 director
2022-07-20 director

James C Momtazee Latest Holdings Summary

James C Momtazee currently owns a total of 1 stock. James C Momtazee owns 88,491 shares of BridgeBio Pharma Inc (BBIO) as of December 29, 2021, with a value of $2 Million.

Latest Holdings of James C Momtazee

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BBIO BridgeBio Pharma Inc 2021-12-29 88,491 27.83 2,462,705

Holding Weightings of James C Momtazee


James C Momtazee Form 4 Trading Tracker

According to the SEC Form 4 filings, James C Momtazee has made a total of 1 transactions in BridgeBio Pharma Inc (BBIO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in BridgeBio Pharma Inc is the acquisition of 80,000 shares on December 29, 2021, which cost James C Momtazee around $1 Million.

Insider Trading History of James C Momtazee

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

James C Momtazee Trading Performance

GuruFocus tracks the stock performance after each of James C Momtazee's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James C Momtazee is -23.47%. GuruFocus also compares James C Momtazee's trading performance to market benchmark return within the same time period. The performance of stocks bought by James C Momtazee within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how James C Momtazee's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of James C Momtazee

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -36.29
Relative Return to S&P 500(%) -28.75

James C Momtazee Ownership Network

Ownership Network List of James C Momtazee

No Data

Ownership Network Relation of James C Momtazee


James C Momtazee Owned Company Details

What does Montes Archimedes Acquisition Corp do?

Who are the key executives at Montes Archimedes Acquisition Corp?

James C Momtazee is the director & 10 percent owner & Chief Executive Officer of Montes Archimedes Acquisition Corp. Other key executives at Montes Archimedes Acquisition Corp include Chief Financial Officer Maria C Walker , and 10 percent owner Patient Square Capital Llc .

Montes Archimedes Acquisition Corp (MAACU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Montes Archimedes Acquisition Corp (MAACU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Montes Archimedes Acquisition Corp (MAACU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Montes Archimedes Acquisition Corp (MAACU)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Montes Archimedes Acquisition Corp Insider Transactions

No Available Data

James C Momtazee Mailing Address

Above is the net worth, insider trading, and ownership report for James C Momtazee. You might contact James C Momtazee via mailing address: 2884 Sand Hill Road, Suite 100, Menlo Park Ca 94025.

Discussions on James C Momtazee

No discussions yet.